Details for 2016793229

Up to date per 05.04.2026

Actions

Title / Product Name

TPP1-FORMULIERUNGEN UND VERFAHREN ZUR BEHANDLUNG VON CLN2 -ERKRANKUNGEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2016793229

EP Publication Number

3294345

E-Number

1621810

Language

PCT Number

US16031074

Publication Date

21.03.2018 A

18.10.2023 B1

Registration Date

18.10.2023

AT Publication Date

15.11.2023

Application Date

05.05.2016

Registration Number

Priorities

08.05.2015

201562158789 P

26.02.2016

201662300171 P

IPC

A61K 9/08 20060101AFI20181213BHEP

Maximum Duration of Protection

05.05.2036

Owner

BioMarin Pharmaceutical Inc.105 Digital Drive Novato, CA 94949US

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

LESTER, Thomas, W.4175 Somerset Ave Castro Valley, CA 94546-3552US

MOSHASHAEE, Saeed1869 Las Gallinas Avenue San Rafael, CA 94903US

OKHAMAFE, Augustus, O.5310 Crystal Ranch Drive Concord, CA 94521US

O'NEILL, Charles, A.P.O. Box 218 Vineburg, CA 95487US

Information about Fees